Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30204247

The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer
Publication date
2018 Nov 1
First author
DuBois SG

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      DuBois SG
      type
      Author
    2. name
      Laetsch TW
      type
      Author
    3. name
      Federman N
      type
      Author
    4. name
      Turpin BK
      type
      Author
    5. name
      Albert CM
      type
      Author
    6. name
      Nagasubramanian R
      type
      Author
    7. name
      Anderson ME
      type
      Author
    8. name
      Davis JL
      type
      Author
    9. name
      Qamoos HE
      type
      Author
    10. name
      Reynolds ME
      type
      Author
    11. name
      Cruickshank S
      type
      Author
    12. name
      Cox MC
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      DuBois SG
      type
      Author
    2. name
      Laetsch TW
      type
      Author
    3. name
      Federman N
      type
      Author
    4. name
      Turpin BK
      type
      Author
    5. name
      Albert CM
      type
      Author
    6. name
      Nagasubramanian R
      type
      Author
    7. name
      Anderson ME
      type
      Author
    8. name
      Davis JL
      type
      Author
    9. name
      Qamoos HE
      type
      Author
    10. name
      Reynolds ME
      type
      Author
    11. name
      Cruickshank S
      type
      Author
    12. name
      Cox MC
      type
      Author
    bibliography ids
    1. nci-bib-7abf5cc9ef15a86bffdd35b8
    book metadata
    content sha256
    7bfb0c9a5b5c22b540b3b3f89261b600641420aaa4df95ca50ebfd0be0d9c566
    document type
    citation
    dois
    1. 10.1002/cncr.31701
    electronic publication date
    display
    2018 Sep 11
    precision
    day
    year
    2018
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:30204247
    immutable id
    pubmed:30204247@7bfb0c9a5b5c22b540b3b3f89261b600641420aaa4df95ca50ebfd0be0d9c566
    journal
    abbreviation
    Cancer
    issn electronic
    1097-0142
    issn print
    0008-543X
    issue
    21
    name
    Cancer
    nlm unique id
    0374236
    pages
    4241-4247
    volume
    124
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      30204247
      provenance
      batch id
      438b2803888025c6cf56
      provider
      NCBI PubMed ESummary
      record sha256
      90c59638f82216bf1211ee376581a08f2e6ea2d876baf3de551ed147ea871938
      response sha256
      0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
      retrieved at
      2026-09-09T23:47:36.359220+00:00
      publication date
      display
      2018 Nov 1
      precision
      day
      year
      2018
      publication types
      1. Clinical Trial, Phase I
      2. Clinical Trial, Phase II
      3. Journal Article
      4. Research Support, N.I.H., Extramural
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/30204247/
      title
      The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas.

      Preserved source evidence · Not medical advice